Neogenomics Inc expected to post a loss of 11 cents a share - Earnings Preview

NeoGenomics

04/08/2023 19:37

* Neogenomics Inc  NEO.OQ   NEO.O  is expected to show a
rise in
quarterly revenue when it reports  results on August 8. 
    * The Fort Myers Florida-based  company is expected to
report  a
9.9% increase in revenue to $137.423 million from $125.07
million a year ago, according to the mean estimate from 12
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Neogenomics Inc is
for a
loss of 11 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Neogenomics
Inc
is $21​, above​ its last closing price of $15.93. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.15       -0.15      -0.09     Beat    40.5
 Dec. 31 2023  -0.15       -0.16      -0.06     Beat    63.6
 Sep. 30 2022  -0.20       -0.21      -0.14     Beat    32​
 Jun. 30 2022  -0.20       -0.23      -0.16     Beat    29
 ​​Mar.        -0.24       -0.24      -0.20     Beat    15
 31 2022                                                
 Dec. 31 2021  -0.14       -0.15      -0.14     Beat    3.8​
 Sep. 30 2021  -0.09       -0.09      -0.08     Beat    6.5
 Jun. 30 2021  -0.06       -0.06      -0.01     Beat    84.2
 This summary was machine generated August 4 at 18:37 GMT.  All
figures in US dollars  unless otherwise stated